Lpl Financial LLC Collegium Pharmaceutical, Inc Transaction History

Lpl Financial LLC

  • $238 Billion
  • Q4 2024

A detailed history of Lpl Financial LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Lpl Financial LLC holds 61,204 shares of COLL stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,204
Previous 65,539 6.61%
Holding current value
$1.87 Million
Previous $2.53 Million 30.77%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$28.61 - $41.86 $124,024 - $181,463
-4,335 Reduced 6.61%
61,204 $1.75 Million
Q3 2024

Nov 08, 2024
SELL
$31.4 - $39.07 $36,738 - $45,711
-1,170 Reduced 1.75%
65,539 $2.53 Million
Q2 2024

Aug 07, 2024
SELL
$31.36 - $39.99 $1.35 Million - $1.72 Million
-43,077 Reduced 39.24%
66,709 $2.15 Million
Q1 2024

May 10, 2024
SELL
$31.23 - $40.91 $315,173 - $412,863
-10,092 Reduced 8.42%
109,786 $4.26 Million
Q4 2023

Feb 14, 2024
SELL
$21.16 - $30.8 $199,559 - $290,474
-9,431 Reduced 7.29%
119,878 $3.69 Million
Q3 2023

Nov 13, 2023
SELL
$21.23 - $24.28 $269,896 - $308,671
-12,713 Reduced 8.95%
129,309 $2.89 Million
Q2 2023

Jul 31, 2023
SELL
$21.06 - $24.0 $345,236 - $393,432
-16,393 Reduced 10.35%
142,022 $3.05 Million
Q1 2023

May 10, 2023
BUY
$23.0 - $29.88 $159,896 - $207,725
6,952 Added 4.59%
158,415 $3.8 Million
Q4 2022

Feb 07, 2023
BUY
$16.14 - $23.55 $159,511 - $232,744
9,883 Added 6.98%
151,463 $3.51 Million
Q3 2022

Nov 14, 2022
SELL
$15.46 - $20.1 $392,637 - $510,479
-25,397 Reduced 15.21%
141,580 $2.27 Million
Q2 2022

Aug 12, 2022
SELL
$14.22 - $20.88 $1,535 - $2,255
-108 Reduced 0.06%
166,977 $2.96 Million
Q1 2022

May 16, 2022
BUY
$17.2 - $22.5 $152,220 - $199,125
8,850 Added 5.59%
167,085 $3.4 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $502,372 - $612,894
-28,707 Reduced 15.36%
158,235 $2.96 Million
Q3 2021

Nov 15, 2021
SELL
$17.75 - $25.39 $114,168 - $163,308
-6,432 Reduced 3.33%
186,942 $3.69 Million
Q2 2021

Aug 13, 2021
SELL
$21.74 - $25.28 $42,632 - $49,574
-1,961 Reduced 1.0%
193,374 $4.57 Million
Q1 2021

May 14, 2021
BUY
$19.25 - $26.1 $22,734 - $30,824
1,181 Added 0.61%
195,335 $4.63 Million
Q4 2020

Feb 12, 2021
SELL
$17.83 - $22.29 $103,057 - $128,836
-5,780 Reduced 2.89%
194,154 $3.89 Million
Q3 2020

Nov 09, 2020
SELL
$15.78 - $20.82 $185,478 - $244,718
-11,754 Reduced 5.55%
199,934 $4.16 Million
Q2 2020

Aug 13, 2020
SELL
$15.49 - $23.51 $25,124 - $38,133
-1,622 Reduced 0.76%
211,688 $3.71 Million
Q1 2020

May 14, 2020
SELL
$13.89 - $25.45 $9,889 - $18,120
-712 Reduced 0.33%
213,310 $3.48 Million
Q4 2019

Feb 14, 2020
BUY
$10.7 - $22.24 $63,354 - $131,683
5,921 Added 2.85%
214,022 $4.41 Million
Q3 2019

Nov 13, 2019
SELL
$10.16 - $13.28 $1,330 - $1,739
-131 Reduced 0.06%
208,101 $2.39 Million
Q2 2019

Aug 09, 2019
BUY
$10.62 - $16.59 $104,160 - $162,714
9,808 Added 4.94%
208,232 $2.74 Million
Q1 2019

May 08, 2019
SELL
$13.58 - $18.72 $21,986 - $30,307
-1,619 Reduced 0.81%
198,424 $3 Million
Q4 2018

Feb 07, 2019
SELL
$14.78 - $19.68 $12,119 - $16,137
-820 Reduced 0.41%
200,043 $3.44 Million
Q3 2018

Nov 14, 2018
BUY
$14.16 - $24.3 $121,181 - $207,959
8,558 Added 4.45%
200,863 $2.96 Million
Q2 2018

Aug 14, 2018
BUY
$21.79 - $28.29 $715,779 - $929,298
32,849 Added 20.6%
192,305 $4.59 Million
Q1 2018

May 15, 2018
BUY
$18.15 - $29.21 $151,933 - $244,516
8,371 Added 5.54%
159,456 $4.07 Million
Q4 2017

Feb 14, 2018
BUY
$9.3 - $19.14 $84,462 - $173,829
9,082 Added 6.4%
151,085 $2.79 Million
Q3 2017

Nov 14, 2017
SELL
$9.15 - $11.97 $3,046 - $3,986
-333 Reduced 0.23%
142,003 $1.49 Million
Q2 2017

Aug 14, 2017
BUY
N/A
142,336
142,336 $1.78 Million

Others Institutions Holding COLL

# of Institutions
248
Shares Held
37.5M
Call Options Held
100K
Put Options Held
10K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.04B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email